Abstract
ABSTRACT
Major depressive disorder (MDD) remains a significant risk to adolescent health and well-being, recently amplified by the COVID-19 pandemic. Access to adolescent mental health care services remains challenging in many areas, resulting in many adolescents diagnosed with MDD remaining untreated. Primary care providers are becoming increasingly crucial in promptly diagnosing and treating this concern. Various clinical guidelines can support clinicians in developing strategies for screening, diagnosing, and managing a vulnerable population with MDD. Standardized screenings, algorithms, and treatment guidelines can help improve the quality of life and functional impairment of those with MDD.
Publisher
Ovid Technologies (Wolters Kluwer Health)
Reference27 articles.
1. Treatment of depression in children and adolescents: a systematic review;Viswanathan
2. Clinical practice guideline for the assessment and treatment of children and adolescents with major and persistent depressive disorders;Walter;J Am Acad Child Adolesc Psychiatry,2023
3. Evidence mapping of clinical practice guidelines recommendations and quality for depression in children and adolescents;Yan;Eur Child Adolesc Psychiatry,2023
4. Child and adolescent psychiatric disorders and psychosocial aspects of pediatrics;Kelsay;Current Diagnosis & Treatment: Pediatrics,2022
5. Addressing adolescent health care and well-being through financial incentives;Javed,2021